Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab(†)

BACKGROUND. The use of bevacizumab for recurrent glioblastoma is controversial. Here we show data on patients who responded to bevacizumab, then stopped bevacizumab for any reason other than progression and were rechallenged with bevacizumab at the time of subsequent progression. METHODS. This retro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Pract
Main Authors: Balaña, Carmen, Estival, Anna, Pineda, Estela, Sepúlveda, Juan, Mesía, Carles, del Barco, Sonia, Gil-Gil, Miguel, Hardy, Max, Indacoechea, Alberto, Cardona, Andrés Felipe
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6655406/
https://ncbi.nlm.nih.gov/pubmed/31385992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npw004
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares